Juvenile idiopathic arthritis (JIA) differs markedly from adult rheumatoid arthritis. It is not a single disease, but an exclusion diagnosis that gather together all forms of arthritis that begin before the age of 16years, persist for more than 6weeks, and are of unknown origin. The advent of the new biological treatments has dramatically...
-
2011 (v1)PublicationUploaded on: April 14, 2023
-
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2021 (v1)Publication
Purpose of Review: Providing a summary of the latest research on outcome measures in juvenile idiopathic arthritis, childhood -onset systemic lupus erythematosus, and juvenile dermatomyositis. Recent Findings: A rational management of patients with pediatric rheumatic diseases requires the regular assessment of the level of disease activity and...
Uploaded on: March 27, 2023 -
2017 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Childhood-onset systemic lupus erythematosus (cSLE) is rare in many regions of the world, including Europe. Access to approved medications for cSLE is currently limited, among others, due to a lack of high-quality evidence from clinical trials. The objectives of the study were to evaluate the current regulatory framework regarding medication...
Uploaded on: April 14, 2023